Global Drugs Based on Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery
According to our (Global Info Research) latest study, the global Drugs Based on Gene Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Drugs Based on Gene Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Drugs Based on Gene Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Drugs Based on Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Drugs Based on Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Drugs Based on Gene Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs Based on Gene Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs Based on Gene Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Drugs Based on Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Based on Viral
    Based on Non-viral

Market segment by Application
    Neurological Diseases
    Cancer
    Other

Market segment by players, this report covers
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    Bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drugs Based on Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drugs Based on Gene Therapy, with revenue, gross margin and global market share of Drugs Based on Gene Therapy from 2018 to 2023.
Chapter 3, the Drugs Based on Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Drugs Based on Gene Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs Based on Gene Therapy.
Chapter 13, to describe Drugs Based on Gene Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Drugs Based on Gene Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Drugs Based on Gene Therapy by Type
        1.3.1 Overview: Global Drugs Based on Gene Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Drugs Based on Gene Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Based on Viral
        1.3.4 Based on Non-viral
    1.4 Global Drugs Based on Gene Therapy Market by Application
        1.4.1 Overview: Global Drugs Based on Gene Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Neurological Diseases
        1.4.3 Cancer
        1.4.4 Other
    1.5 Global Drugs Based on Gene Therapy Market Size & Forecast
    1.6 Global Drugs Based on Gene Therapy Market Size and Forecast by Region
        1.6.1 Global Drugs Based on Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Drugs Based on Gene Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Drugs Based on Gene Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Drugs Based on Gene Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Drugs Based on Gene Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Drugs Based on Gene Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Drugs Based on Gene Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Drugs Based on Gene Therapy Product and Solutions
        2.1.4 Biogen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Drugs Based on Gene Therapy Product and Solutions
        2.2.4 Novartis Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Drugs Based on Gene Therapy Product and Solutions
        2.3.4 Gilead Sciences Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Gilead Sciences Recent Developments and Future Plans
    2.4 Sarepta Therapeutics
        2.4.1 Sarepta Therapeutics Details
        2.4.2 Sarepta Therapeutics Major Business
        2.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Product and Solutions
        2.4.4 Sarepta Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.5 Alnylam Pharmaceuticals
        2.5.1 Alnylam Pharmaceuticals Details
        2.5.2 Alnylam Pharmaceuticals Major Business
        2.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product and Solutions
        2.5.4 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Drugs Based on Gene Therapy Product and Solutions
        2.6.4 Amgen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Drugs Based on Gene Therapy Product and Solutions
        2.7.4 Spark Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Spark Therapeutics Recent Developments and Future Plans
    2.8 Akcea Therapeutics
        2.8.1 Akcea Therapeutics Details
        2.8.2 Akcea Therapeutics Major Business
        2.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Product and Solutions
        2.8.4 Akcea Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Akcea Therapeutics Recent Developments and Future Plans
    2.9 Bluebird bio
        2.9.1 Bluebird bio Details
        2.9.2 Bluebird bio Major Business
        2.9.3 Bluebird bio Drugs Based on Gene Therapy Product and Solutions
        2.9.4 Bluebird bio Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Bluebird bio Recent Developments and Future Plans
    2.10 Sunway Biotech
        2.10.1 Sunway Biotech Details
        2.10.2 Sunway Biotech Major Business
        2.10.3 Sunway Biotech Drugs Based on Gene Therapy Product and Solutions
        2.10.4 Sunway Biotech Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Drugs Based on Gene Therapy Product and Solutions
        2.11.4 SIBIONO Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Drugs Based on Gene Therapy Product and Solutions
        2.12.4 AnGes Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Product and Solutions
        2.13.4 Orchard Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans
    2.14 Human Stem Cells Institute
        2.14.1 Human Stem Cells Institute Details
        2.14.2 Human Stem Cells Institute Major Business
        2.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Product and Solutions
        2.14.4 Human Stem Cells Institute Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Drugs Based on Gene Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Drugs Based on Gene Therapy by Company Revenue
        3.2.2 Top 3 Drugs Based on Gene Therapy Players Market Share in 2022
        3.2.3 Top 6 Drugs Based on Gene Therapy Players Market Share in 2022
    3.3 Drugs Based on Gene Therapy Market: Overall Company Footprint Analysis
        3.3.1 Drugs Based on Gene Therapy Market: Region Footprint
        3.3.2 Drugs Based on Gene Therapy Market: Company Product Type Footprint
        3.3.3 Drugs Based on Gene Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Drugs Based on Gene Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Drugs Based on Gene Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Drugs Based on Gene Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Drugs Based on Gene Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Drugs Based on Gene Therapy Consumption Value by Type (2018-2029)
    6.2 North America Drugs Based on Gene Therapy Consumption Value by Application (2018-2029)
    6.3 North America Drugs Based on Gene Therapy Market Size by Country
        6.3.1 North America Drugs Based on Gene Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Drugs Based on Gene Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Drugs Based on Gene Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Drugs Based on Gene Therapy Market Size by Country
        7.3.1 Europe Drugs Based on Gene Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Drugs Based on Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Drugs Based on Gene Therapy Consumption Value by Type (2018-2029)
    9.2 South America Drugs Based on Gene Therapy Consumption Value by Application (2018-2029)
    9.3 South America Drugs Based on Gene Therapy Market Size by Country
        9.3.1 South America Drugs Based on Gene Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Drugs Based on Gene Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Drugs Based on Gene Therapy Market Drivers
    11.2 Drugs Based on Gene Therapy Market Restraints
    11.3 Drugs Based on Gene Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Drugs Based on Gene Therapy Industry Chain
    12.2 Drugs Based on Gene Therapy Upstream Analysis
    12.3 Drugs Based on Gene Therapy Midstream Analysis
    12.4 Drugs Based on Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Drugs Based on Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Drugs Based on Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Drugs Based on Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Drugs Based on Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Biogen Company Information, Head Office, and Major Competitors
    Table 6. Biogen Major Business
    Table 7. Biogen Drugs Based on Gene Therapy Product and Solutions
    Table 8. Biogen Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Biogen Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Drugs Based on Gene Therapy Product and Solutions
    Table 13. Novartis Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 16. Gilead Sciences Major Business
    Table 17. Gilead Sciences Drugs Based on Gene Therapy Product and Solutions
    Table 18. Gilead Sciences Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Gilead Sciences Recent Developments and Future Plans
    Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 21. Sarepta Therapeutics Major Business
    Table 22. Sarepta Therapeutics Drugs Based on Gene Therapy Product and Solutions
    Table 23. Sarepta Therapeutics Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Sarepta Therapeutics Recent Developments and Future Plans
    Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 26. Alnylam Pharmaceuticals Major Business
    Table 27. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product and Solutions
    Table 28. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Table 30. Amgen Company Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Drugs Based on Gene Therapy Product and Solutions
    Table 33. Amgen Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Amgen Recent Developments and Future Plans
    Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 36. Spark Therapeutics Major Business
    Table 37. Spark Therapeutics Drugs Based on Gene Therapy Product and Solutions
    Table 38. Spark Therapeutics Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Spark Therapeutics Recent Developments and Future Plans
    Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
    Table 41. Akcea Therapeutics Major Business
    Table 42. Akcea Therapeutics Drugs Based on Gene Therapy Product and Solutions
    Table 43. Akcea Therapeutics Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Akcea Therapeutics Recent Developments and Future Plans
    Table 45. Bluebird bio Company Information, Head Office, and Major Competitors
    Table 46. Bluebird bio Major Business
    Table 47. Bluebird bio Drugs Based on Gene Therapy Product and Solutions
    Table 48. Bluebird bio Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Bluebird bio Recent Developments and Future Plans
    Table 50. Sunway Biotech Company Information, Head Office, and Major Competitors
    Table 51. Sunway Biotech Major Business
    Table 52. Sunway Biotech Drugs Based on Gene Therapy Product and Solutions
    Table 53. Sunway Biotech Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Sunway Biotech Recent Developments and Future Plans
    Table 55. SIBIONO Company Information, Head Office, and Major Competitors
    Table 56. SIBIONO Major Business
    Table 57. SIBIONO Drugs Based on Gene Therapy Product and Solutions
    Table 58. SIBIONO Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. SIBIONO Recent Developments and Future Plans
    Table 60. AnGes Company Information, Head Office, and Major Competitors
    Table 61. AnGes Major Business
    Table 62. AnGes Drugs Based on Gene Therapy Product and Solutions
    Table 63. AnGes Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. AnGes Recent Developments and Future Plans
    Table 65. Orchard Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. Orchard Therapeutics Major Business
    Table 67. Orchard Therapeutics Drugs Based on Gene Therapy Product and Solutions
    Table 68. Orchard Therapeutics Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Orchard Therapeutics Recent Developments and Future Plans
    Table 70. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
    Table 71. Human Stem Cells Institute Major Business
    Table 72. Human Stem Cells Institute Drugs Based on Gene Therapy Product and Solutions
    Table 73. Human Stem Cells Institute Drugs Based on Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Human Stem Cells Institute Recent Developments and Future Plans
    Table 75. Global Drugs Based on Gene Therapy Revenue (USD Million) by Players (2018-2023)
    Table 76. Global Drugs Based on Gene Therapy Revenue Share by Players (2018-2023)
    Table 77. Breakdown of Drugs Based on Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Drugs Based on Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 79. Head Office of Key Drugs Based on Gene Therapy Players
    Table 80. Drugs Based on Gene Therapy Market: Company Product Type Footprint
    Table 81. Drugs Based on Gene Therapy Market: Company Product Application Footprint
    Table 82. Drugs Based on Gene Therapy New Market Entrants and Barriers to Market Entry
    Table 83. Drugs Based on Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Drugs Based on Gene Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 85. Global Drugs Based on Gene Therapy Consumption Value Share by Type (2018-2023)
    Table 86. Global Drugs Based on Gene Therapy Consumption Value Forecast by Type (2024-2029)
    Table 87. Global Drugs Based on Gene Therapy Consumption Value by Application (2018-2023)
    Table 88. Global Drugs Based on Gene Therapy Consumption Value Forecast by Application (2024-2029)
    Table 89. North America Drugs Based on Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 90. North America Drugs Based on Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 91. North America Drugs Based on Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. North America Drugs Based on Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. North America Drugs Based on Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 94. North America Drugs Based on Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 95. Europe Drugs Based on Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Europe Drugs Based on Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Europe Drugs Based on Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 98. Europe Drugs Based on Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 99. Europe Drugs Based on Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Drugs Based on Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 102. Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 103. Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 104. Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 105. Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 106. Asia-Pacific Drugs Based on Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 107. South America Drugs Based on Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 108. South America Drugs Based on Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 109. South America Drugs Based on Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 110. South America Drugs Based on Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 111. South America Drugs Based on Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. South America Drugs Based on Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 115. Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 116. Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 118. Middle East & Africa Drugs Based on Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 119. Drugs Based on Gene Therapy Raw Material
    Table 120. Key Suppliers of Drugs Based on Gene Therapy Raw Materials
List of Figures
    Figure 1. Drugs Based on Gene Therapy Picture
    Figure 2. Global Drugs Based on Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Drugs Based on Gene Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Based on Viral
    Figure 5. Based on Non-viral
    Figure 6. Global Drugs Based on Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Drugs Based on Gene Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Neurological Diseases Picture
    Figure 9. Cancer Picture
    Figure 10. Other Picture
    Figure 11. Global Drugs Based on Gene Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Drugs Based on Gene Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Drugs Based on Gene Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Drugs Based on Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Drugs Based on Gene Therapy Consumption Value Market Share by Region in 2022
    Figure 16. North America Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Drugs Based on Gene Therapy Revenue Share by Players in 2022
    Figure 22. Drugs Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Drugs Based on Gene Therapy Market Share in 2022
    Figure 24. Global Top 6 Players Drugs Based on Gene Therapy Market Share in 2022
    Figure 25. Global Drugs Based on Gene Therapy Consumption Value Share by Type (2018-2023)
    Figure 26. Global Drugs Based on Gene Therapy Market Share Forecast by Type (2024-2029)
    Figure 27. Global Drugs Based on Gene Therapy Consumption Value Share by Application (2018-2023)
    Figure 28. Global Drugs Based on Gene Therapy Market Share Forecast by Application (2024-2029)
    Figure 29. North America Drugs Based on Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Drugs Based on Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Drugs Based on Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Drugs Based on Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Drugs Based on Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Drugs Based on Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Drugs Based on Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Drugs Based on Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Drugs Based on Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Drugs Based on Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Drugs Based on Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Drugs Based on Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Drugs Based on Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Drugs Based on Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Drugs Based on Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Drugs Based on Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. Drugs Based on Gene Therapy Market Drivers
    Figure 64. Drugs Based on Gene Therapy Market Restraints
    Figure 65. Drugs Based on Gene Therapy Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Drugs Based on Gene Therapy in 2022
    Figure 68. Manufacturing Process Analysis of Drugs Based on Gene Therapy
    Figure 69. Drugs Based on Gene Therapy Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute